Skip to main content
. 2020 Jun 9;124(9):922–930. doi: 10.1017/S0007114520002044

Table 4.

Effect of dietary supplementation with fish oil (FO) or Camelina sativa seed oil (CSO) on plasma glucose and lipid concentrations*

(Mean values with their standard errors; n 31)

Concentration (mmol/l)
Start End Difference Start v. end Δ FO v. Δ CSO
Mean sem Mean sem Mean sem P P
TAG
 FO 1·0 0·1 0·8 0·1 −0·2 0·1 0·02 0·4
 CSO 0·9 0·1 0·8 0·1 −0·1 0·1 0·1
Cholesteryl esters
 FO 2·9 0·2 3·0 0·3 0·2 0·1 0·2 0·7
 CSO 3·1 0·3 3·2 0·3 0·1 0·2 0·4
NEFA
 FO 0·3 0·1 3·0 0·1 0·1 0·1 0·3 0·4
 CSO 0·1 0·1 0·1 0·1 0·1 0·1 0·9
Glucose
 FO 4·8 0·1 4·6 0·1 −0·2 0·1 0·04 0·9
 CSO 4·8 0·1 4·8 0·1 0·1 0·1 0·5
*

All data approximated a normal distribution. The mean concentrations of EPA and DHA at the start and end of the trial and the effect of the type of oil on the mean change in EPA and DHA concentrations from baseline were analysed using Student’s paired t test.